Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
22
NCT05218616
The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 21, 2022
Completion: May 3, 2022